A Preliminary Study of Melatonin in Irritable Bowel Syndrome
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND AIMS: Melatonin is involved in the regulation of gut motility and sensation. We aimed to determine if melatonin was effective in improving bowel symptoms, extracolonic symptoms, and quality of life (QOL) in irritable bowel syndrome (IBS) patients. METHODS: Eighteen patients (aged 18 to 65 y; 6 females) were randomly assigned to receive either melatonin 3 mg (n=9) or matching placebo (n=9) at bed time for 8 weeks. The overall IBS scores, extracolonic IBS scores, QOL scores were assessed at 2, 4, 6, and 8 weeks during treatment and at 16, 24, and 48 weeks during follow up. RESULTS: Compared with placebo, melatonin taken for 8 weeks significantly improved overall IBS score (45% vs. 16.66%, P<0.05). The posttreatment overall extracolonic IBS score was significantly lower (49.16% to 13.88%, P<0.05) when compared with placebo group. The overall improvement in QOL score was 43.63% in melatonin group and 14.64% in placebo group that is statistically significant. CONCLUSIONS: The result of this study showed that melatonin has some beneficial role in IBS. Further studies using large number of patients may provide a definite answer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drossman, D. A., Li, Z., Andruzzi, E., Temple, R. D., Talley, N. J., Grant Thompson, W., Whitehead, W. E., Janssens, J., Funch-Jensen, P., Corazziari, E., et al. (1993) · Digestive Diseases and Sciences · doi:10.1007/bf01303162 · Cited by 2,198
Brzezinski, A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701163360306 · Cited by 1,549
Dunlop, S. P., Jenkins, D., Neal, K. R., & Spiller, R. C. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.09.028 · Cited by 583
Non-colonic features of irritable bowel syndrome.
Whorwell, P. J., McCallum, M., Creed, F. H., & Roberts, C. T. (1986) · Gut · doi:10.1136/gut.27.1.37 · Cited by 473
Medical costs in community subjects with irritable bowel syndrome
Talley, N. J., Gabriel, S. E., Harmsen, W. S., Zinsmeister, A. R., & Evans, R. W. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90738-6 · Cited by 460 · cited 4×
“5 Extracolonic features [median (interquartile ranges)] Nausea/vomiting 30 (3-50) 40 (5-80) >0.”
Influential
Cited by
Melatonin: Buffering the Immune System
Carrillo-Vico, A., Lardone, P., Álvarez-Sánchez, N., Rodríguez-Rodríguez, A., & Guerrero, J. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14048638 · Cited by 740
Distribution, function and physiological role of melatonin in the lower gut
Chen, C.-Q. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i34.3888 · Cited by 255
Melatonin: From Pharmacokinetics to Clinical Use in Autism Spectrum Disorder
Lalanne, S., Fougerou-Leurent, C., Anderson, G. M., Schroder, C. M., Nir, T., Chokron, S., Delorme, R., Claustrat, B., Bellissant, E., Kermarrec, S., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031490 · Cited by 90
Recent developments in the therapy of irritable bowel syndrome
Saad, R. J., & Chey, W. D. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.2.117 · Cited by 21
Metadata
- Authors
- Saha, L., Malhotra, S., Rana, S., Bhasin, D., & Pandhi, P.
- Venue
- Journal of Clinical Gastroenterology
- Published
- 2007-01
- Volume
- 41
- Issue
- 1
- Pages
- 29-32
- ISSN
- 0192-0790 (ISSN-L)
- OpenAlex
- W2003030349
- Cited by
- 79
- References
- 5
- FWCI
- 2.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.